Tuesday, May 21, 2024 · SEC filings
What the smart money revealed on May 21
875 insider filings came in. We hid 67 planned (10b5-1) sellers and 594 people whose filings were routine, like grants and tax withholding.
Immunome (IMNM) President and CEO Clay Siegall bought $1.39M
100,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Synovus Financial (SNV) EVP and CFO Andrew Gregory Jr. bought $1.12M
28,000 shares on the open market. Not a grant or an option exercise.
Cummins (CMI) VP - Chief Human Resources Off Marvin Boakye bought $499K
1,745 shares on the open market. Not a grant or an option exercise.
RxSight (RXST) Director Juliet Tammenoms Bakker bought $305K
5,000 shares on the open market. Not a grant or an option exercise.
Carlisle Companies (CSL) Chair D. Christian Koch sold $24.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 86,652 shares directly.
Gulfport Energy (GPOR) CLAO and Corp Secretary Patrick Craine sold $10.8M
Not marked as a planned 10b5-1 sale. Sold 69% of the shares they held directly. Still holds 31,484 shares.
Qualcomm (QCOM) Director Neil Smit sold $617K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 45 more real buys
Show 144 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, May 15–21
Open-market buys by officers and directors, filed in the 7 days up to May 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.